Overview

• Elizabeth Holmes remains incarcerated in Texas, serving a reduced sentence for defrauding Theranos investors, with release now set for 2032.
• Billy Evans, Holmes's partner, is seeking $50 million in funding for Haemanthus, a diagnostics startup billed as 'the future of diagnostics.'
• Haemanthus plans to initially develop diagnostic tools for pets before potentially expanding to human applications, though timelines remain unclear.
• Evans has reportedly raised millions so far, primarily from personal networks, but broader funding efforts are ongoing.
• The startup operates in stealth mode, and its regulatory strategy and product launch timeline have yet to be disclosed.